Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B U Sevin

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assayH Gallion, W A Christopherson, R L Coleman, et al.
Gynecologic Oncology|May 1, 1995
Paclitaxel: a radiation sensitizer of human cervical cancer cellsM Rodriguez, B U Sevin, J Perras, et al.
Breast Cancer Research and Treatment|October 1, 1993
Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Gynecologic Oncology|March 1, 1993
Radical hysterectomy for stage IB adenocarcinoma of the cervix: the University of Miami experienceA Steren, H N Nguyen, H E Averette, et al.
Anti-Cancer Drugs|February 1, 1995
In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasmsO R Koechli, G N Schaer, B U Sevin, et al.
Gynecologic Oncology|October 1, 1991
Cell kinetic perturbations after irradiation and caffeine in the BG-1 ovarian carcinoma cell lineE H Wolloch, B U Sevin, J P Perras, et al.
Oncology|January 1, 1992
Rationale of combining radiation and interferon for the treatment of cervical cancerR Angioli, B U Sevin, J P Perras, et al.
Cancer|May 1, 1993
Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cellsR Angioli, M Untch, B U Sevin, et al.
Gynecologic Oncology|April 1, 1996
Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trialJ P Curtin, W J Hoskins, E S Venkatraman, et al.
Gynecologic Oncology|September 1, 1990
Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell lineG M Boike, E Petru, B U Sevin, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2006
Progression-free interval in ovarian cancer and predictive value of an ex vivo chemoresponse assayH Gallion, W A Christopherson, R L Coleman, et al.
Gynecologic Oncology|May 1, 1995
Paclitaxel: a radiation sensitizer of human cervical cancer cellsM Rodriguez, B U Sevin, J Perras, et al.
Breast Cancer Research and Treatment|October 1, 1993
Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-cell viability assayO R Koechli, B U Sevin, J P Perras, et al.
Gynecologic Oncology|March 1, 1993
Radical hysterectomy for stage IB adenocarcinoma of the cervix: the University of Miami experienceA Steren, H N Nguyen, H E Averette, et al.
Anti-Cancer Drugs|February 1, 1995
In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasmsO R Koechli, G N Schaer, B U Sevin, et al.
Gynecologic Oncology|October 1, 1991
Cell kinetic perturbations after irradiation and caffeine in the BG-1 ovarian carcinoma cell lineE H Wolloch, B U Sevin, J P Perras, et al.
Oncology|January 1, 1992
Rationale of combining radiation and interferon for the treatment of cervical cancerR Angioli, B U Sevin, J P Perras, et al.
Cancer|May 1, 1993
Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cellsR Angioli, M Untch, B U Sevin, et al.
Gynecologic Oncology|April 1, 1996
Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trialJ P Curtin, W J Hoskins, E S Venkatraman, et al.
Gynecologic Oncology|September 1, 1990
Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell lineG M Boike, E Petru, B U Sevin, et al.
Pageof 14